Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SR One names Jens Eckstein president

This article was originally published in Scrip

Executive Summary

Jens Eckstein has been named president of SR One, GSK's independent healthcare venture organisation, effective 1 October. Mr Eckstein will replace Christoph Westphal who is leaving GSK at the end of the year to focus on external business interests, including the Longwood Founder's Fund in which GSK is an investor. Mr Eckstein has served at TVM Capital since 2004, currently as venture partner and entrepreneur-in-residence. He is also currently interim CEO and president of SelectX Pharmaceuticals.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts